Lung cancer is the most common cancer worldwide.
It is also the most common cause of death from cancer in the world.
Even though early detection and diagnosis has improved, lung cancer is often diagnosed at an advanced stage and has poor prognosis.
It is known that a quick diagnose and tumor detection of lung cancers in early stages is essential, given that this type of cancer is considered very aggressive and with risk of misdiagnosis. Because of this, nowadays there is an important medical need to accomplish techniques for an early diagnosis; even more in high-risk patients, as smokers.
We aim to develop an algorithm to detect patients at high risk of lung cancer.
Our test –almost non-invasive, easy to include in regular check-ups and low cost– can potentially solve the lack of screening techniques for this cancer.
The first data analysis of the lung study is being compiled and initial results appear highly positive.
The results show a great potential to use our results as the new screening tool for early lung cancer detection.
The European Commission recently awarded us the European Seal of Excellence for our project proposal in lung cancer research.
Cancer remains the leading cause of death from disease among children.
The most common types of cancer among young patients are leukemias, brain and other central nervous system (CNS) tumors, and lymphomas.
Children’s cancer is very different from adult, in terms of incidence (much lower), lack of preventive measures, therapy and response to medication. Therefore, adult cancer research results cannot be extrapolated to children’s cancer cases.
As in any disease, clinical research is the key to finding a cure; however, properly executed clinical trials require significant funding which is primarily devoted to diseases that affect large numbers of patients.
In general, cancer in children is uncommon, so it can be hard for doctors to determine the best treatment unless they know what has been most effective in other children. That’s why more than 60% of children younger than 15 years of age with cancer are treated as part of a clinical trial.
We have conducted the largest research project ever done in childhood cancer. Samples from approximately 100 children with cancer, as well as matching healthy children.
The objective of these studies was to throw light on how telomere dynamics can contribute to allow oncologists and hematologists to take better and more informed treatment decisions, thereby increasing the chances for beating the cancer and giving these children the opportunity to live a long and healthy life.
These studies were performed with the support of one of the most important children’s hospitals in Spain, Hospital Infantil Universitario Niño Jesús.
Our other studies under the ONCOCHECK PROJECT
Advanced solid tumors and Chronic Lymphocytic Leukemia
Leukemia is a cancer of the blood. Chronic Lymphocytic Leukemia (CLL), a cancer of the lymphocytes, is the most common type of leukemia in adults. Lymphocytes are a type of white blood cells involved in the body’s immune system. CLL is more common in older adults and the average age of people diagnosed with CLL is 71.